S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7129 +0.28%
PRE-MKT · 06:30 ET
Market ClerkRecap
Thu Oct 22 · pre-market2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
LA
INSIDER · CATX · Perspective Therapeutics, Inc. · 10% OWNER

Lantheus Alpha Therapy, LLC

Every open-market transaction filed under this name, Aug 31 to Sep 4.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 4CATXPerspective Therapeutics, Inc.10% ownerSell167,149$3.15$526K—
Sep 3CATXPerspective Therapeutics, Inc.10% ownerSell80,783$3.11$251K—
Sep 2CATXPerspective Therapeutics, Inc.10% ownerSell42,129$3.11$131K—
Sep 1CATXPerspective Therapeutics, Inc.10% ownerSell35,769$3.12$112K—
Aug 31CATXPerspective Therapeutics, Inc.10% ownerSell78,145$3.14$246K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.